ERS International Congress 2023: highlights from the Pulmonary Vascular Diseases Assembly

Mostra el registre complet Registre parcial de l'ítem

• dc.contributor.author Cullivan, Sarah
• dc.contributor.author Boucly, Athénaïs
• dc.contributor.author Jevnikar, Mitja
• dc.contributor.author Lechartier, Benoit
• dc.contributor.author Ulrich, Silvia
• dc.contributor.author Bertoletti, Laurent
• dc.contributor.author Sitbon, Olivier
• dc.contributor.author Vonk-Noordegraaf, Anton
• dc.contributor.author Bokan, Aleksandar
• dc.contributor.author Park, Da-Hee
• dc.contributor.author Genecand, Leon
• dc.contributor.author Guiot, Julien
• dc.contributor.author Jutant, Etienne-Marie
• dc.contributor.author Piccari, Lucilla
• dc.contributor.author Lichtblau, Mona
• dc.date.accessioned 2024-10-14T06:27:57Z
• dc.date.available 2024-10-14T06:27:57Z
• dc.date.issued 2024
• dc.description.abstract Pulmonary vascular diseases such as pulmonary embolism and pulmonary hypertension are important and frequently under-recognised conditions. This article provides an overview of key highlights in pulmonary vascular diseases from the European Respiratory Society International Congress 2023. This includes insights into disease modification in pulmonary arterial hypertension and novel therapies such as sotatercept and seralutinib. Exciting developments in our understanding of the mechanisms underpinning pulmonary hypertension associated with interstitial lung disease are also explored. A comprehensive overview of the complex relationship between acute pulmonary embolism and chronic thromboembolic pulmonary hypertension (CTEPH) is provided along with our current understanding of the molecular determinants of CTEPH. The importance of multidisciplinary and holistic care cannot be understated, and this article also addresses advances beyond medication, with a special focus on exercise training and rehabilitation.
• dc.format.mimetype application/pdf
• dc.identifier.citation Cullivan S, Boucly A, Jevnikar M, Lechartier B, Ulrich S, Bertoletti L, et al. ERS International Congress 2023: highlights from the Pulmonary Vascular Diseases Assembly. ERJ Open Res. 2024 Feb 26;10(1):00847-2023. DOI: 10.1183/23120541.00847-2023
• dc.identifier.doi http://dx.doi.org/10.1183/23120541.00847-2023
• dc.identifier.issn 2312-0541
• dc.identifier.uri http://hdl.handle.net/10230/61377
• dc.language.iso eng
• dc.publisher European Respiratory Society
• dc.relation.ispartof ERJ Open Res. 2024 Feb 26;10(1):00847-2023
• dc.rights Copyright © The authors 2024. This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0 (http://creativecommons.org/licenses/by-nc/4.0/). For commercial reproduction rights and permissions contact permissions@ersnet.org
• dc.rights.accessRights info:eu-repo/semantics/openAccess
• dc.rights.uri http://creativecommons.org/licenses/by-nc/4.0/
• dc.subject.other Vasos sanguinis--Malalties
• dc.subject.other Embòlia pulmonar
• dc.subject.other Hipertensió pulmonar
• dc.title ERS International Congress 2023: highlights from the Pulmonary Vascular Diseases Assembly
• dc.type info:eu-repo/semantics/article
• dc.type.version info:eu-repo/semantics/publishedVersion